Cases of fulminant type 1 and type 2 diabetes mellitus whose HbA1c levels were unmeasurable due to increased labile HbA1c

被引:1
作者
Kato, Shunsuke [1 ]
Otaka, Izumi [1 ]
Toyama, Hanako [1 ]
Kusumi, Ryota [1 ]
Takahashi, Kazuyuki [1 ]
Nara, Mitsuhiko [1 ]
Suganuma, Yumi [1 ]
Sato, Takehiro [1 ]
Morii, Tsukasa [1 ]
Fujita, Hiroki [1 ]
Waki, Hironori [1 ]
机构
[1] Akita Univ, Dept Metab & Endocrinol, Grad Sch Med, 1-1-1 Hondo, Akita 0108543, Japan
关键词
Labile HbA1c; HPLC; Hyperglycemia; Fulminant type 1 diabetes; Type; 2; diabetes; HEMOGLOBIN; GLUCOSE; IDENTIFICATION; ACETALDEHYDE; ASSAYS; HPLC;
D O I
10.1007/s13340-022-00593-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the measurement of hemoglobin A1c (HbA1c) using high-performance liquid chromatography (HPLC) is routinely used to estimate average blood glucose levels, it may not be accurately measured for various reasons, such as alteration of red blood cell lifespan and the existence of hemoglobin variants; including hemoglobin F (HbF). Here, we report cases of fulminant type 1 and type 2 diabetes mellitus in which HbA1c levels were unmeasurable because of increased labile HbA1c levels. Case 1 involved a 73-year-old man with fulminant type 1 diabetes mellitus, who was brought to our hospital with diabetic ketoacidosis. The patient's blood glucose level was 994 mg/dL, and HbA1c was unmeasurable, which turned out to be 6.2% on the next day when the blood glucose level was normalized. Case 2 involved a 72-year-old man with type 2 diabetes mellitus, whose blood glucose level was 767 mg/dL, and HbA1c was unmeasurable, which turned out to be 17.9% the following day. In both cases, the chromatograms showed that the HbA1c peaks overlapped with large labile HbA1c peaks, which decreased the next day. It is important to keep in mind that HbA1c levels may not be accurately measured in cases of extreme hyperglycemia because of an increase in labile HbA1c, regardless of the absolute HbA1c level.
引用
收藏
页码:698 / 703
页数:6
相关论文
共 27 条
[1]   Comparison of Arkray/ELITech ADAMS HA-8180V® with Bio-Rad Variant,™II Turbo2.0® and Tosoh Bioscience HLC®-723G8 for HbA1c Determination [J].
Badiou, Stephanie ;
Guillot, Julie ;
Kuster, Nils ;
Bargnoux, Anne-Sophie ;
Aguilar-Martinez, Patricia ;
Boissier, Elodie ;
Cristol, Jean-Paul ;
Dupuy, Anne-Marie .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2014, 28 (06) :428-434
[2]   ACETYLATION OF HEMOGLOBIN BY ASPIRIN - INVITRO AND INVIVO [J].
BRIDGES, KR ;
SCHMIDT, GJ ;
JENSEN, M ;
CERAMI, A ;
BUNN, HF .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (01) :201-207
[3]  
Bry L, 2001, CLIN CHEM, V47, P153
[4]  
BUNN HF, 1981, DIABETES, V30, P613
[5]   Labile glycated hemoglobin: an underestimated laboratory marker of short term glycemia [J].
Delanghe, Joris R. ;
Lambrecht, Stijn ;
Fiers, Tom ;
Speeckaert, Marijn M. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (03) :451-455
[6]   HEMOGLOBIN CARBAMYLATION IN UREMIA [J].
FLUCKIGER, R ;
HARMON, W ;
MEIER, W ;
LOO, S ;
GABBAY, KH .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (14) :823-827
[7]  
globin.bx.psu.edu, SUMM MUT CAT
[8]   Tests of glycemia in diabetes [J].
Goldstein, DE ;
Little, RR ;
Lorenz, RA ;
Malone, JI ;
Nathan, D ;
Peterson, CM ;
Sacks, DB .
DIABETES CARE, 2004, 27 (07) :1761-1773
[9]  
Goyal R., 2019, J CLIN EXP INVESTIG, V11, DOI 10.5799/jcei/6340
[10]   QUANTITATIVE MEASUREMENT OF HBA(1C) BY AN IMMUNOTURBIDIMETRIC ASSAY COMPARED TO A STANDARD HPLC METHOD [J].
HAMWI, A ;
SCHWEIGER, CR ;
VEITL, M ;
SCHMID, R .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1995, 104 (01) :89-95